Macrocephaly is a condition in which circumference of the human head is abnormally large. It may be pathological or harmless, and can be a familial genetic characteristic. People diagnosed with macrocephaly will receive further medical tests to determine whether the syndrome is accompanied by particular disorders. Those with benign or familial macrocephaly are considered to have megalencephaly.

Causes

Many people with abnormally large heads or large skulls are healthy, but macrocephaly may be pathological. Pathologic macrocephaly may be due to megalencephaly (enlarged brain), hydrocephalus (abnormally increased cerebrospinal fluid), cranial hyperostosis (bone overgrowth), and other conditions. Pathologic macrocephaly is called "syndromic", when it is associated with any other noteworthy condition, and "nonsyndromic" otherwise. Pathologic macrocephaly may be caused by congenital anatomic abnormalities, genetic conditions, or by environmental events. (also known as basal cell nevus syndrome) and cardiofaciocutaneous syndrome; Fragile X syndrome; leukodystrophies (brain white matter degeneration) such as Alexander disease, Canavan disease, and megalencephalic leukoencephalopathy with subcortical cysts; and glutaric aciduria type 1 and D-2-hydroxyglutaric aciduria.

Environmental events associated with macrocephaly include infection, neonatal intraventricular hemorrhage (bleeding within the infant brain), subdural hematoma (bleeding beneath the outer lining of the brain), subdural effusion (collection of fluid beneath the outer lining of the brain), and arachnoid cysts (cysts on the brain surface).

Below is a list of conditions featuring macrocephaly from NCBI's MedGen:

  • Achondroplasia
  • Acrocallosal syndrome
  • Adams-Oliver syndrome
  • Adenosine kinase deficiency
  • Antley-Bixler syndrome
  • Autosomal dominant Kenny-Caffey syndrome
  • Autosomal recessive osteopetrosis
  • Axenfeld-Rieger anomaly
  • B4GALT1-congenital disorder of glycosylation
  • Bardet-Biedl syndrome
  • Brittle cornea syndrome
  • Camptomelic dysplasia
  • Cardio-facio-cutaneous syndrome
  • Cobblestone lissencephaly without muscular or ocular involvement
  • Coffin-Siris syndrome
  • Cohen-Gibson syndrome
  • Cole-Carpenter syndrome
  • Congenital disorder of glycosylation, type Iw, autosomal dominant
  • Corpus callosum, agenesis of
  • Costello syndrome
  • Cowden syndrome
  • Craniodiaphyseal dysplasia, autosomal dominant
  • Cranioectodermal dysplasia
  • Craniometaphyseal dysplasia
  • Craniosynostosis
  • D-2-hydroxyglutaric aciduria
  • Deficiency of alpha-mannosidase
  • Desmosterolosis
  • Donnai-Barrow syndrome
  • Early-onset parkinsonism-intellectual disability syndrome
  • Ehlers-Danlos syndrome, spondylodysplastic type
  • Epidermolysis bullosa simplex
  • Fragile X syndrome
  • Giant axonal neuropathy
  • Glutaric aciduria, type 1
  • Gorlin syndrome
  • Greenberg dysplasia
  • Greig cephalopolysyndactyly syndrome
  • Hamartoma of hypothalamus
  • Holoprosencephaly
  • Hurler syndrome

thumb|Macrocephaly from hydrocephalus

  • Hydrocephalus, nonsyndromic, autosomal recessive
  • Hypochondroplasia
  • Hypophosphatemic rickets and hyperparathyroidism
  • Hypothyroidism, congenital, nongoitrous
  • Ito hypomelanosis
  • Joubert syndrome
  • Keipert syndrome
  • Legius syndrome
  • LEOPARD syndrome
  • Lethal congenital contracture syndrome
  • MASA syndrome

thumb|Macrocephaly from megalencephaly

  • Megalencephaly, autosomal dominant
  • Megalocornea-intellectual disability syndrome
  • MGAT2-congenital disorder of glycosylation
  • MOMO syndrome
  • Mucopolysaccharidosis type 6
  • Mucopolysaccharidosis type 7
  • Mucopolysaccharidosis, MPS-II
  • Mucopolysaccharidosis, MPS-III-D
  • Muenke syndrome
  • Multiple acyl-CoA dehydrogenase deficiency
  • Multiple congenital anomalies-hypotonia-seizures syndrome
  • Multiple epiphyseal dysplasia, Al-Gazali type
  • Myhre syndrome
  • Neurofibromatosis, type 1
  • Neurofibromatosis-Noonan syndrome
  • Niemann-Pick disease, type A
  • Noonan syndrome
  • Opsismodysplasia
  • Optic atrophy
  • Osteopathia striata with cranial sclerosis
  • Pallister-Killian syndrome
  • Parietal foramina
  • Parietal foramina with cleidocranial dysplasia
  • Pelger-Huët anomaly
  • Peroxisome biogenesis disorder 1A (Zellweger)
  • Peroxisome biogenesis disorder 4B
  • Phelan-McDermid syndrome
  • Plasminogen deficiency, type I
  • Primrose syndrome
  • Proteus syndrome
  • Ritscher-Schinzel syndrome
  • Robinow syndrome
  • Sandhoff disease
  • Schneckenbecken dysplasia
  • Sclerosteosis
  • Severe X-linked myotubular myopathy
  • Sialuria
  • Simpson-Golabi-Behmel syndrome
  • Snijders Blok-Campeau syndrome
  • Sotos syndrome
  • Sturge-Weber syndrome
  • Sulfite oxidase deficiency due to molybdenum cofactor deficiency
  • Symphalangism with multiple anomalies of hands and feet
  • Syndromic X-linked intellectual disability
  • Thanatophoric dysplasia type 1
  • Vanishing white matter disease
  • Weaver syndrome
  • X-linked dominant chondrodysplasia, Chassaing-Lacombe type
  • X-linked hydrocephalus syndrome
  • X-linked intellectual disability with marfanoid habitus
  • Zimmermann-Laband syndrome
  • ZTTK syndrome

Diagnosis

Macrocephaly is customarily diagnosed if head circumference is greater than two standard deviations (SDs) above the mean. Relative macrocephaly occurs if the measure is less than two SDs above the mean, but is disproportionately above that when ethnicity and stature are considered. Diagnosis can be determined in utero or can be determined within 18–24 months after birth in some cases where head circumference tends to stabilize in infants. Diagnosis in infants includes measuring the circumference of the child's head and comparing how significant it falls above the 97.5 percentile of children similar to their demographic. If falling above the 97.5th percentile then the patient will be checked to determine whether there is any intracranial pressure present and whether or not immediate surgery is needed. While benign and familial macrocephaly do not result in neurological disorders, neurodevelopment will still need to be assessed.

Although neurological disorders do not occur, temporary symptoms of benign and familial macrocephaly include: developmental delay, epilepsy, and mild hypotonia.

  • Postnatal macrocephaly: macrocephaly developed postnatally (after birth).
  • Progressive macrocephaly: macrocephaly developed progressively over time.
  • Relative macrocephaly: mild macrocephaly measured under 2 SD from mean, but larger in appearance due to other factors (ex. short stature).

Treatment

Treatment varies depending on whether or not it occurs with other medical conditions in the child and where the cerebrospinal fluid is present.

If excess fluid is found between the ventricle spaces in the brain then surgery will be needed.